AquaBounty’s genetically engineered AquAdvantage salmon is once again going through a U.S. Food and Drug Administration (FDA) environmental assessment (EA) after a lawsuit by multiple organizations led to a court order for additional analysis.
The FDA granted permission for the salmon to be sold in the U.S. in 2015, but a judge ruled in 2020 the agency needed to perform additional review of the salmon to evaluate the chances it could be introduced into the wild and its subsequent danger to wild salmon populations. A judge in San Francisco ruled the FDA did not do its due diligence when considering the possibility of environmental consequences with its approval of the salmon.
“The FDA did not, however, meaningfully analyze what might happen to normal salmon in the event the engineered salmon did survive and establish themselves in the wild,” U.S. District Court of Northern California Judge Vince Chhabria wrote. “Even if this scenario was unlikely, the FDA was still required to assess the consequences of it coming to pass.”…
Recent Comments